Bruce Philip Pritchard
Chief Executive Officer at LIMINAL BIOSCIENCES INC.
Profile
Bruce Philip Pritchard is currently the Chief Executive Officer at Liminal BioSciences, Inc. since 2020.
He also holds the position of Non-Executive Director at Being Digital Ltd., Porton Biopharma Ltd., Fairhaven Pharmaceuticals, Inc., and Scottish Global Health Foundation.
In his former roles, Mr. Pritchard served as the Chief Executive Officer & Director at ProMetic Plasma Resources, Inc. He was also a Senior Director at CV Therapeutics, Inc. from 2004 to 2006 and Finance Director at Ardana Plc from 2003 to 2004.
Additionally, he held positions as a Director at Astrea Bioseparations Ltd., Non-Executive Director at Imanova Ltd.
from 2012 to 2017, Director at Liminal BioSciences Ltd., and Chief Financial Officer at ProMetic BioSciences Ltd.
Mr. Pritchard is a Member of The Institute of Chartered Accountants of Scotland from 2009 to 2015.
He was also a Member-Examiners Board at The Institute of Directors (United Kingdom) from 2011 to 2016.
Mr. Pritchard obtained his undergraduate degree from Heriot-Watt University in 1993.
Bruce Philip Pritchard active positions
| Companies | Position | Start |
|---|---|---|
| LIMINAL BIOSCIENCES INC. | Chief Executive Officer | 2020-11-12 |
| Scottish Global Health Foundation | Director/Board Member | 2009-08-27 |
| Being Digital Ltd. | Director/Board Member | - |
Fairhaven Pharmaceuticals, Inc.
 Fairhaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Fairhaven Pharmaceuticals, Inc. engages in the research and development of small molecule antagonists that target chemoattractant and activator of eosinophils, which play a key role in type 2 inflammation-driven diseases. The company was founded on May 4, 2018 and is headquartered in Laval, Canada. | Director/Board Member | - |
Porton Biopharma Ltd.
 Porton Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Porton Biopharma Ltd. is a biopharmaceutical company based in Salisbury, UK. The British company is focused on the development and manufacture of biopharmaceutical products for the treatment of infectious diseases and cancer. Porton Biopharma is committed to delivering high-quality products that meet the needs of patients and healthcare providers. The CEO of the private company is Roger Hinton, who leads a team of experienced professionals dedicated to advancing the company's mission. | Director/Board Member | - |
Former positions of Bruce Philip Pritchard
| Companies | Position | End |
|---|---|---|
Imanova Ltd.
 Imanova Ltd. BiotechnologyHealth Technology Imanova Ltd. provides research and development solutions in biomarkers. It offers clinical imaging, preclinical imaging, analysis and consultancy, access to academic expertise, and consumer health. The company was founded in 2011 and is headquartered in London, the United Kingdom. | Director/Board Member | 2017-08-31 |
The Institute of Directors (United Kingdom)
 The Institute of Directors (United Kingdom) Miscellaneous Commercial ServicesCommercial Services The Institute of Directors (United Kingdom) is a community of passionate UK business leaders. The non-profit company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The British company provides professional training opportunities and access to essential help and resources for its members. The CEO of the company is Stephen Martin. | Corporate Officer/Principal | 2016-04-30 |
The Institute of Chartered Accountants of Scotland
 The Institute of Chartered Accountants of Scotland Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants of Scotland operates as a professional membership organization. The non-profit company is based in Edinburgh, UK. The British company was founded by Janice Margaret Brown and Sundeep Bahanda. The CEO is Bruce Cartwright. | Corporate Officer/Principal | 2015-02-28 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Corporate Officer/Principal | 2006-08-31 |
| ░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Bruce Philip Pritchard
| Heriot-Watt University | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LIMINAL BIOSCIENCES INC. | Health Technology |
| Private companies | 13 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Ardana Plc
 Ardana Plc Pharmaceuticals: MajorHealth Technology Ardana Plc developed pharmaceuticals products. It offered Invicorp, an intracavernosal injectable combination of phentolamine mesilate and vasoactive intestinal polypeptide for the treatment of male erectile dysfunction. The company was founded in 2000 and was headquartered in Bristol, the United Kingdom. | Health Technology |
Astrea Bioseparations Ltd.
 Astrea Bioseparations Ltd. Medical SpecialtiesHealth Technology Astrea Bioseparations Ltd. develops and manufactures affinity purification technology. It specializes in affinity chromatography and bioseparations, specifically purification of proteins and the elimination of contaminants including pathogens. The company was founded in 1987 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
The Institute of Chartered Accountants of Scotland
The Institute of Chartered Accountants of Scotland Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants of Scotland operates as a professional membership organization. The non-profit company is based in Edinburgh, UK. The British company was founded by Janice Margaret Brown and Sundeep Bahanda. The CEO is Bruce Cartwright. | Commercial Services |
ProMetic BioSciences Ltd.
 ProMetic BioSciences Ltd. Miscellaneous Commercial ServicesCommercial Services ProMetic BioSciences Ltd. operates as a biopharmaceutical company. The company was founded by Christopher Robin Low and is headquartered in Laval, Canada. | Commercial Services |
| Scottish Global Health Foundation | |
The Institute of Directors (United Kingdom)
The Institute of Directors (United Kingdom) Miscellaneous Commercial ServicesCommercial Services The Institute of Directors (United Kingdom) is a community of passionate UK business leaders. The non-profit company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The British company provides professional training opportunities and access to essential help and resources for its members. The CEO of the company is Stephen Martin. | Commercial Services |
Imanova Ltd.
Imanova Ltd. BiotechnologyHealth Technology Imanova Ltd. provides research and development solutions in biomarkers. It offers clinical imaging, preclinical imaging, analysis and consultancy, access to academic expertise, and consumer health. The company was founded in 2011 and is headquartered in London, the United Kingdom. | Health Technology |
| Being Digital Ltd. | |
Porton Biopharma Ltd.
Porton Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Porton Biopharma Ltd. is a biopharmaceutical company based in Salisbury, UK. The British company is focused on the development and manufacture of biopharmaceutical products for the treatment of infectious diseases and cancer. Porton Biopharma is committed to delivering high-quality products that meet the needs of patients and healthcare providers. The CEO of the private company is Roger Hinton, who leads a team of experienced professionals dedicated to advancing the company's mission. | Health Technology |
Liminal BioSciences Ltd.
 Liminal BioSciences Ltd. BiotechnologyHealth Technology Part of Liminal R & D BioSciences, Inc., Liminal BioSciences Ltd. is a British biopharmaceutical company founded in 2015. The private company is based in Comberton, UK. The company is focused on the discovery and development of novel, small molecule drug candidates. | Health Technology |
ProMetic Plasma Resources, Inc.
 ProMetic Plasma Resources, Inc. Medical/Nursing ServicesHealth Services Part of Grifols SA, ProMetic Plasma Resources, Inc. operates plasma donation centers. The private company is based in Winnipeg, Canada. ProMetic Plasma Resources was acquired by Grifols Canada Therapeutics, Inc. from Kedrion SpA on January 04, 2022 for $3.13 million. | Health Services |
Fairhaven Pharmaceuticals, Inc.
Fairhaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Fairhaven Pharmaceuticals, Inc. engages in the research and development of small molecule antagonists that target chemoattractant and activator of eosinophils, which play a key role in type 2 inflammation-driven diseases. The company was founded on May 4, 2018 and is headquartered in Laval, Canada. | Commercial Services |
- Stock Market
- Insiders
- Bruce Philip Pritchard
